![](https://endpts.com/wp-content/uploads/2020/12/Corey-McCann-Pear-Therapeutics-tile-scaled.jpg)
Pear Therapeutics president and CEO Corey McCann (Pear)
Pear Therapeutics nabs $80M Series D to commercialize three digital therapeutics
As the pandemic rages on, virtual care options have investors champing at the bit. Boston-based Pear Therapeutics is the latest to benefit, reeling in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.